Drug Designing: Open Access

Drug Designing: Open Access
Open Access

ISSN: 2169-0138

+441414719275

Citations Report

Citations Report - Drug Designing: Open Access [22 Articles]

The articles published in Drug Designing: Open Access have been cited 22 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Drug Designing: Open Access.

Waghmare S, Sherkhane A, Gomase V (2015) Computational mapping of MHC class binding nonamers from Fatty-acid and retinol-binding protein 1 of Brugia malayi. Journal of Basic Sciences 1: 45-53.

Mamillapalli V (2016) Nanoparticles for Herbal Extracts. Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm 10.

Tashima T (2015) Possibilities of Cancer Chemotherapy Based on Transporter-Conscious Drug Design. J Carcinog Mutagen 6: 2.

Tashima T (2015) Intriguing possibilities and beneficial aspects of transporter-conscious drug design. Bioorganic & medicinal chemistry 23: 4119-4131.

Divya A. Research and Reviews: Journal of Pharmacology and Toxicological Studies.

Bielecka AM, Obuchowicz E (2016) Antidepressant drugs can modify cytotoxic action of temozolomide. European Journal of Cancer Care.

Li L, Wang J, Zang H, Zhang H, Jiang W, et al. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences.

Gautami, J., Nadu, T. Research and Reviews: Journal of Pharmaceutics and Nanotechnology.

Montes, R., Bernat, B., & Srebalus-Barnes, C. (2016). Statistical Applications for Biosimilar Product Development. In Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics: Selected Papers from the 2015 ICSA/Graybill Applied Statistics Symposium, Colorado State University, Fort Collins (pp. 259-277). Springer International Publishing.

Burdick, R. K., LeBlond, D. J., Pfahler, L. B., Quiroz, J., Sidor, L., Vukovinsky, K., & Zhang, L. (2017). Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry.

Chow, S. C., Song, F., & Bai, H. (2016). Sample Size Requirement in Analytical Studies for Similarity Assessment. Journal of Biopharmaceutical Statistics, (just-accepted).

Krause, S. O. Reducing Analytical Method Steps for Accelerated Product.

Burdick, R. K., LeBlond, D. J., Pfahler, L. B., Quiroz, J., Sidor, L., Vukovinsky, K., & Zhang, L. (2017). Analytical Comparability and Similarity. In Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry (pp. 329-369). Springer International Publishing.

Burdick, R. K., Thomas, N., & Cheng, A. (2017). Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product. Statistics in Biopharmaceutical Research, (just-accepted).

Burdick, R., Coffey, T., Gutka, H., Gratzl, G., Conlon, H. D., Huang, C. T., ... & Kuehne, H. (2017). Statistical Approaches to Assess Biosimilarity from Analytical Data. The AAPS Journal, 19(1), 4-14.

Wang, T., & Chow, S. C. (2016). On establishment of equivalence acceptance criterion in analytical similarity assessment. Journal of Biopharmaceutical Statistics, (just-accepted).

Chow, S. C., Song, F., & Bai, H. (2016). Analytical similarity assessment in biosimilar studies. The AAPS journal, 18(3), 670-677.

Özkay, Y., & Özkay, Ü. D. Acetylcholine Esterase Inhibitory Potential of Some Benzimidazole Derivatives.

Mohsen, U. A. (2014). DERIVATIVES AS ACETYCHOLINESTERASE INHIBITORS.

Moiety, B. D. B. D. Cukurova Medical Journal.

Top